ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - glucose monohydrate, quantity: 42.5 g/l; calcium chloride dihydrate, quantity: 0.184 g/l; magnesium chloride hexahydrate, quantity: 51 mg/l; sodium chloride, quantity: 5.38 g/l; sodium bicarbonate, quantity: 2.1 g/l; sodium lactate, quantity: 1.68 g/l - solution, irrigation - excipient ingredients: water for injections - physioneal 40 is indicated for use in peritoneal dialysis in patients with acute or chronic renal failure.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - glucose monohydrate, quantity: 25 g/l; calcium chloride dihydrate, quantity: 0.184 g/l; magnesium chloride hexahydrate, quantity: 51 mg/l; sodium chloride, quantity: 5.38 g/l; sodium bicarbonate, quantity: 2.1 g/l; sodium lactate, quantity: 1.68 g/l - solution, irrigation - excipient ingredients: water for injections - physioneal 40 is indicated for use in peritoneal dialysis in patients with acute or chronic renal failure.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - glucose monohydrate, quantity: 15 g/l; calcium chloride dihydrate, quantity: 0.184 g/l; magnesium chloride hexahydrate, quantity: 51 mg/l; sodium chloride, quantity: 5.38 g/l; sodium bicarbonate, quantity: 2.1 g/l; sodium lactate, quantity: 1.68 g/l - solution, irrigation - excipient ingredients: water for injections - physioneal 40 is indicated for use in peritoneal dialysis in patients with acute or chronic renal failure.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - glucose monohydrate, quantity: 15 g/l (equivalent: glucose, qty 13.6 g/l); sodium bicarbonate, quantity: 2.1 g/l; sodium chloride, quantity: 5.38 g/l; magnesium chloride hexahydrate, quantity: 51 mg/l; sodium lactate, quantity: 1.68 g/l; calcium chloride dihydrate, quantity: 0.184 g/l - solution, dialysis - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - physioneal 40 is indicated for use in peritoneal dialysis in patients with acute or chronic renal failure.

सिंगापुर - अंग्रेज़ी - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - glucose (as glucose monohydrate) (in compartment 3); glycine (in compartment 2); l-alanine (in compartment 2); l-arginine (in compartment 2); l-histidine (in compartment 2); l-isoleucine (in compartment 2); l-leucine (in compartment 2); l-lysine (as hcl) (in compartment 2); l-methionine (in compartment 2); l-phenylalanine (in compartment 2); l-proline (in compartment 2); l-serine (in compartment 2); l-threonine (in compartment 2); l-tryptophan (in compartment 2); l-tyrosine (in compartment 2); l-valine (in - emulsion - 176.00 g/l - glucose (as glucose monohydrate) (in compartment 3) 176.00 g/l; glycine (in compartment 2) 4.12 g/l; l-alanine (in compartment 2) 8.28 g/l; l-arginine (in compartment 2) 4.60 g/l; l-histidine (in compartment 2) 1.92 g/l; l-isoleucine (in compartment 2) 2.40 g/l; l-leucine (in compartment 2) 2.92 g/l; l-lysine (as hcl) (in compartment 2) 2.90 g/l; l-methionine (in compartment 2) 1.60 g/l; l-phenylalanine (in compartment 2) 2.24 g/l; l-proline (in compartment 2) 2.72 g/l; l-serine (in compartment 2) 2.00 g/l; l-threonine (in compartment 2) 1.68 g/l; l-tryptophan (in compartment 2) 0.72 g/l; l-tyrosine (in compartment 2) 0.16 g/l; l-valine (in compartment 2) 2.32 g/l; refined soya bean oil + refined olive oil (in compartment 1) 40.00 g/l

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose, quantity: 45 g (equivalent: glucose monohydrate, qty 50 g) - injection - excipient ingredients: water for injections - glucose (5%) intravenous infusions are mainly indicated: - whenever non-electrolyte fluid replacement is required. - as a vehicle for drug delivery, provided that the added components are compatible with glucose.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose, quantity: 22.5 g (equivalent: glucose monohydrate, qty 25 g) - injection - excipient ingredients: water for injections - glucose (5%) intravenous infusions are mainly indicated: - whenever non-electrolyte fluid replacement is required. - as a vehicle for drug delivery, provided that the added components are compatible with glucose.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose, quantity: 11.25 g (equivalent: glucose monohydrate, qty 12.5 g) - injection - excipient ingredients: water for injections - glucose (5%) intravenous infusions are mainly indicated: - whenever non-electrolyte fluid replacement is required. - as a vehicle for drug delivery, provided that the added components are compatible with glucose.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - glucose monohydrate, quantity: 55 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. may also be used as solvents for intravenously administered drugs where compatibility has been established.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - glucose monohydrate, quantity: 55 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. may also be used as solvents for intravenously administered drugs where compatibility has been established.